Search results
Weight loss drug shortage: Zepbound and Wegovy in short supply, says FDA
BenefitsPRO· 2 days agoThe U.S. Food and Drug Administration updated its drug shortage database in April to reflect that...
JD Supra: FDA Issues Supplemental Draft Guidance for Premarket Cybersecurity
JD Supra· 51 minutes agoThe U.S. Food and Drug Administration (FDA) recently released its draft guidance with a proposal to add a Section ...
Planters Nuts Recalled in 5 States for Potential Listeria Contamination
allrecipes via Yahoo News· 1 day agoThe recall, initiated in conjunction with the U.S. Food and Drug Administration (FDA), affects two...
An FDA Overreaction to Theranos's Implosion Would Harm Patients
Scientific American· 6 hours agoSuch laboratory developed tests (LDTs), which are created and utilized within individual...
E. coli outbreak: Walnuts sold in at least 19 states linked to illnesses in California and...
USA Today· 4 days agoThe Food and Drug Administration and the Centers for Disease Control and Prevention are...
In a first, FDA approves use of Apple Watch for clinical trials involving abnormal heartbeats
The Washington Times· 1 day agoThe Food and Drug Administration has approved the use of the Apple Watch in clinical trials dealing with atrial fibrillation ...
JD Supra: FDA's View on Cannabis
JD Supra· 1 day agoThe U.S. Food and Drug Administration (FDA) is continuing to support clinical research for cannabis and psychedelic ...
Is Wegovy or Ozempic Better for Weight Loss?
MediaFeed via AOL· 1 day agoWe have answers. Carolina Rudah/istockphoto Wegovy vs. Ozempic: What’s the Difference? Ozempic is approved by the FDA (U.S. Food and Drug
Neurocrine bags FDA approval for new ‘sprinkle’ Ingrezza formulation
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe US Food and Drug Administration (FDA) has approved an alternative formulation for Neurocrine...
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 6 hours ago(NYSE: LLY) is making a name for itself in the diabetes and chronic weight management markets. The...